Zobrazeno 1 - 10 of 33 pro vyhledávání: '"Manceur AM"'
2
Akademický článek
Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Autor: Shadman M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Salkar M; AbbVie, North Chicago, IL, USA., Srivastava B; AbbVie, North Chicago, IL, USA., Karve S; AbbVie, North Chicago, IL, USA., Emond B; Analysis Group, Inc., Montréal, Canada., Gogna P; Analysis Group, Inc., Montréal, Canada., Manceur AM; Analysis Group, Inc., Montréal, Canada., Lafeuille MH; Analysis Group, Inc., Montréal, Canada., Rava A; Genesis Research Group, Hoboken, NJ, USA., Sun H; Genesis Research Group, Hoboken, NJ, USA., Howarth A; Genesis Research Group, Hoboken, NJ, USA., Tomicki S; Genesis Research Group, Hoboken, NJ, USA., Agatep B; Inovalon, Bowie, MD, USA., Jones B; Inovalon, Bowie, MD, USA., Franceschini E; AbbVie, North Chicago, IL, USA., Saifan C; AbbVie, North Chicago, IL, USA., Bacchus S; AbbVie, North Chicago, IL, USA., Roeker L; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stephens DM; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA.
Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Oct 01, pp. 1-10. Date of Electronic Publication: 2024 Oct 01.
Zobrazit plný text záznamu
3
Akademický článek
Economic and clinical burden of chronic corticosteroid use in patients with Crohn[apos]s disease initiated on biologic or conventional therapies in the US: A retrospective claims study.
Autor: Zhdanava M, Zhao R, Manceur AM, Ding Z, Boudreau J, Kachroo S, Kerner C, Izanec J, Pilon D
Publikováno v: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 Mar-Apr; Vol. 64 (2), pp. 386-394.e10. Date of Electronic Publication: 2023 Nov 11.
Zobrazit plný text záznamu
4
Akademický článek
Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States.
Autor: Zhdanava M; Analysis Group, Inc., Montréal, QC, Canada., Zhao R; Janssen Scientific Affairs, LLC, Horsham, PA., Manceur AM; Analysis Group, Inc., Montréal, QC, Canada., Ding Z; Janssen Scientific Affairs, LLC, Horsham, PA., Boudreau J; Analysis Group, Inc., Montréal, QC, Canada., Kachroo S; Janssen Scientific Affairs, LLC, Horsham, PA., Kerner C; Janssen Scientific Affairs, LLC, Horsham, PA., Izanec J; Janssen Scientific Affairs, LLC, Horsham, PA., Pilon D; Analysis Group, Inc., Montréal, QC, Canada.
Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Feb 03; Vol. 30 (2), pp. 141-152.
Zobrazit plný text záznamu
5
Akademický článek
Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH).
Autor: DuBrock HM; Mayo Clinic, Rochester, MN, USA., Germack HD; Medical Affairs, Johnson and Johnson Innovative Medicines, Titusville, NJ, USA., Gauthier-Loiselle M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0M7, Canada. Marjolaine.Gauthier-Loiselle@analysisgroup.com., Linder J; Janssen-Cilag GmbH, Neuss, Germany., Satija A; Analysis Group, Inc., Boston, MA, USA., Manceur AM; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0M7, Canada., Cloutier M; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0M7, Canada., Lefebvre P; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0M7, Canada., Panjabi S; Medical Affairs, Johnson and Johnson Innovative Medicines, Titusville, NJ, USA., Frantz RP; Mayo Clinic, Rochester, MN, USA.
Publikováno v: PharmacoEconomics - open [Pharmacoecon Open] 2024 Jan; Vol. 8 (1), pp. 133-146. Date of Electronic Publication: 2023 Nov 18.
Zobrazit plný text záznamu
6
Akademický článek
Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens.
Autor: Marrett E; Health Economics and Outcomes Research, Daiichi Sankyo, Inc., 211 Mt Airy Rd, Basking Ridge, NJ, 07920, USA. emarrett@dsi.com., Kwong WJ; Health Economics and Outcomes Research, Daiichi Sankyo, Inc., 211 Mt Airy Rd, Basking Ridge, NJ, 07920, USA., Xie J; Analysis Group, Los Angeles, CA, USA., Manceur AM; Analysis Group, Montreal, QC, Canada., Sendhil SR; Analysis Group, Los Angeles, CA, USA., Wu E; Analysis Group, Boston, MA, USA., Ionescu-Ittu R; Analysis Group, Montreal, QC, Canada., Subramanian J; Inova Schar Cancer Institute, Fairfax, VA, USA.
Publikováno v: Drugs - real world outcomes [Drugs Real World Outcomes] 2023 Dec; Vol. 10 (4), pp. 531-544. Date of Electronic Publication: 2023 Sep 02.
Zobrazit plný text záznamu
7
Akademický článek
Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
Autor: Sargent T; HonorHealth, 8125 N Hayden Road, Scottsdale, AZ, 85258, USA., Tsang Y; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Panjabi S; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Funtanilla V; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Germack HD; Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Gauthier-Loiselle M; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montreal, QC, H3B 0M7, Canada. Marjolaine.Gauthier-Loiselle@analysisgroup.com., Manceur AM; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Montreal, QC, H3B 0G7, Canada., Cloutier M; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Montreal, QC, H3B 0G7, Canada., Lefebvre P; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Montreal, QC, H3B 0G7, Canada.
Publikováno v: Advances in therapy [Adv Ther] 2023 Nov; Vol. 40 (11), pp. 5037-5054. Date of Electronic Publication: 2023 Sep 20.
Zobrazit plný text záznamu
8
Akademický článek
Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States.
Autor: Zhdanava M; Analysis Group, Inc., Montreal, QC, Canada., Zhao R; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Manceur AM; Analysis Group, Inc., Montreal, QC, Canada., Kachroo S; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Lefebvre P; Analysis Group, Inc., Montreal, QC, Canada., Pilon D; Analysis Group, Inc., Montreal, QC, Canada.
Publikováno v: Crohn's & colitis 360 [Crohns Colitis 360] 2023 Sep 04; Vol. 5 (3), pp. otad045. Date of Electronic Publication: 2023 Sep 04 (Print Publication: 2023).
Zobrazit plný text záznamu
9
Akademický článek
Long-term persistence and other treatment patterns among bio-naïve patients with Crohn's disease treated with ustekinumab or adalimumab.
Autor: Zhdanava M; Analysis Group, Inc, Montréal, QC, Canada., Ding Z; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Manceur AM; Analysis Group, Inc, Montréal, QC, Canada., Zhao R; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Holiday C; Analysis Group, Inc, Montréal, QC, Canada., Kachroo S; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Izanec J; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Pilon D; Analysis Group, Inc, Montréal, QC, Canada.
Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2023 Sep; Vol. 39 (9), pp. 1215-1225. Date of Electronic Publication: 2023 Aug 26.
Zobrazit plný text záznamu
10
Akademický článek
Persistence and other treatment patterns among bio-experienced patients with Crohn's disease initiated on ustekinumab or adalimumab.
Autor: Zhdanava M; Analysis Group, Inc., Montreal, QC, Canada., Zhao R; Janssen Scientific Affairs, LLC, Horsham, PA., Manceur AM; Analysis Group, Inc., Montreal, QC, Canada., Ding Z; Janssen Scientific Affairs, LLC, Horsham, PA., Kachroo S; Janssen Scientific Affairs, LLC, Horsham, PA., Holiday C; Analysis Group, Inc., Montreal, QC, Canada., Lefebvre P; Analysis Group, Inc., Montreal, QC, Canada., Pilon D; Analysis Group, Inc., Montreal, QC, Canada.
Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Aug; Vol. 29 (8), pp. 907-916.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje